original ) (raw )Dissection of prostate tumour, stroma and immune transcription reveals a key contribution by the microenvironment to disease progression
Michael Kerger
2020
View PDFchevron_right
Localized prostate cancer: can we better define who is at risk of unfavourable outcome?
Hein Van Poppel
BJU International, 2008
View PDFchevron_right
Underlying Features of Prostate Cancer—Statistics, Risk Factors, and Emerging Methods for Its Diagnosis
Jorge Pereira
Current Oncology
View PDFchevron_right
Bio-Clinical Parameters with a Predictive Role in Advanced Prostate Cancer
Anita Mitu
2021
View PDFchevron_right
The prostate cancer conundrum revisited
ruth etzioni
Cancer, 2012
View PDFchevron_right
Predictors of Histological Disease Progression in Untreated, Localized Prostate Cancer
ramachandran venkitaraman
The Journal of Urology, 2007
View PDFchevron_right
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Yudi Pawitan , Stefano Calza
BMC Medical Genomics, 2010
View PDFchevron_right
Prostate Cancer: New Insights into Minimal and Localised Disease: Active Surveillance
Laurent Boccon-Gibod
European Urology Supplements, 2009
View PDFchevron_right
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Sue Merson
European urology focus, 2018
View PDFchevron_right
Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria
Alejandro Godoy
Urologia Internationalis
View PDFchevron_right
Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates
Ray Merrill
Cancer, 2002
View PDFchevron_right
The molecular staging of prostate cancer
Noel Clarke
BJU International, 2004
View PDFchevron_right
Editorial: Prostate Cancer: What We Know and What We Would Like to Know
Richard Cote
Frontiers in Oncology, 2015
View PDFchevron_right
Evaluation of prediagnostic prostate‐specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
Hans Lilja
2011
View PDFchevron_right
Identification of Most Aggressive Carcinoma Among Patients Diagnosed With Prostate Cancer Using Mathematical Modeling of Prostate-Specific Antigen Increases
Mélanie Wilbaux
Clinical Genitourinary Cancer, 2016
View PDFchevron_right
Prognostic Factors in Localised Prostate Cancer with Emphasis on the Application of Molecular Techniques
Marcel Tilanus
European Urology, 2002
View PDFchevron_right
Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
maria athelogou
Scientific reports, 2018
View PDFchevron_right
One size fits all in prostate cancer: a story tale whose time has come and gone
Ali Nawaz
The International Journal of Biological Markers, 2011
View PDFchevron_right
Prediction of Pathological Stage in Patients with Clinical Stage T1c Prostate Cancer: The New Challenge
Robert Veltri
The Journal of Urology, 2002
View PDFchevron_right
Does the Presence of Primary Circulating Prostate Cells Imply the Presence of Agressive Prostate Cancer with Early Biochemical Failure: a Comparison with the Walz Nomogram
Sebastian Orellana
2016
View PDFchevron_right
Biomarker expression patterns that correlate with high grade features in treatment naive, organ-confined prostate cancer
REMIGIO LOPEZ
BMC Medical Genomics, 2008
View PDFchevron_right
Malignant field expression signatures in biopsy samples at diagnosis predict the likelihood of lethal disease in patients with localized prostate cancer
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2017
View PDFchevron_right
Delineation of prognostic biomarkers in prostate cancer
Debashis Ghosh
Nature, 2001
View PDFchevron_right
Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer
Michelangelo Fiorentino
View PDFchevron_right
Multiple Tissue Biomarkers Independently and Additively Predict Prostate Cancer Pathology Outcomes
Andrew Avila
European Urology, 2021
View PDFchevron_right
ProCOC: The prostate cancer outcomes cohort study
Tulio Sulser
BMC Urology, 2008
View PDFchevron_right
The cellular and molecular basis of prostate cancer
Philip Cornford
BJU International, 2001
View PDFchevron_right
Long‐Term assessment of prostate cancer progression free survival: Evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis
Robert Veltri
The Prostate, 2008
View PDFchevron_right
Biochemical staging of prostate cancer
eduardo canto
Urologic Clinics of North America, 2003
View PDFchevron_right
Evaluation of the Current Prostate Cancer Staging System Based on Cancer-Specific Mortality in the Surveillance, Epidemiology, and End Results Database
Chandana Reddy
Clinical Genitourinary Cancer, 2015
View PDFchevron_right
Molecular markers and mortality in prostate cancer
Dhanpat Jain
BJU International, 2007
View PDFchevron_right